Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications

N Engl J Med. 1974 Sep 12;291(11):544-7. doi: 10.1056/NEJM197409122911102.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Blood Glucose / metabolism*
  • Depression, Chemical
  • Diabetes Mellitus / blood*
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / physiopathology
  • Diabetes Mellitus / therapy
  • Female
  • Glucagon / blood*
  • Glucagon / metabolism
  • Growth Hormone / blood
  • Growth Hormone / metabolism
  • Growth Hormone-Releasing Hormone / antagonists & inhibitors*
  • Humans
  • Hypoglycemia / drug therapy
  • Hypophysectomy
  • Injections, Intravenous
  • Injections, Subcutaneous
  • Insulin / administration & dosage
  • Insulin / therapeutic use
  • Male
  • Middle Aged
  • Pancreas / metabolism
  • Peptides / administration & dosage
  • Peptides / pharmacology*
  • Peptides / therapeutic use

Substances

  • Blood Glucose
  • Insulin
  • Peptides
  • Growth Hormone
  • Glucagon
  • Growth Hormone-Releasing Hormone